MassIVE MSV000095810

Partial Public

Persistent IgG1 clones dominate and personalize the plasma antibody repertoire

Subscribe Comment Convert Spectra Add Reanalysis

Description

Antibodies play a pivotal role in the immune defense and long-term immunity. Yet, while several studies have highlighted the long durability of antigen-specific antibody responses, it is unclear whether this durability stems from the continuous production of the same clones or the recurrent activation of B cells generating new clones over time. To gain insights into the long-term stability of the human antibody repertoire, we monitored the concentrations of hundreds of the most abundant IgG1 antibody clones in plasma samples of 11 healthy donors at 9 sampling points over a year. During this year, each donor received 3 doses of a COVID-19 vaccine. Notwithstanding these vaccinations, the concentrations of the most abundant individual IgG1 clones remained extraordinarily constant throughout the year. Given the 2-3 week turn-over of IgG1 molecules in blood, our data suggest that these abundant clones are primarily associated with long-term immunity rather than being induced by acute infections or vaccinations. These dominant clones do not undergo further somatic hypermutation over the year and are therefore likely produced consistently by long-lived plasma cells. The long-term stability of dominant IgG1 clones was observed in all donors, although there was no overlap in any of the detected clones when comparing IgG1 repertoires across donors. While most dominant IgG1 clones remained constant throughout the year, a small subset emerged later and remained stable thereafter, whereas another subset decreased in concentration. Overall, our data suggests that the vast majority of abundant IgG1 clones in plasma are persistently produced by long-lived plasma cells. [doi:10.25345/C5DZ03D10] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: IgG1 clonal profiling, Longtitudinal study, LC-MS, LLPC, long-term immunity

Contact

Principal Investigators:
(in alphabetical order) 		Albert J.R. Heck, Biomolecular Mass Spectrometry and Proteomics groups, Utrecht University, N/A
Submitting User: DaniquevanRijswijck
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

Species

Instrument

Modifications

- Dataset Reanalyses

+ Dataset History

Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.